Cizzle Biotechnology Holdings Plc (LON:CIZ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.700
+0.200 (13.33%)
Mar 5, 2026, 8:39 AM GMT
Market Cap5.95M -21.1%
Revenue (ttm)n/a
Net Income-1.12M
EPS-0.00
Shares Out396.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,799
Average Volume436,023
Open1.700
Previous Close1.500
Day's Range1.700 - 1.700
52-Week Range0.012 - 1.700
Beta0.53
RSI56.46
Earnings DateApr 30, 2026

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 4
Stock Exchange London Stock Exchange
Ticker Symbol CIZ
Full Company Profile

Financial Performance

Financial Statements